HOYA CORPORATION
7741・Prime Market・Precision Instruments
Business
HOYA Corporation traces its origins to an optical glass manufacturer founded in 1941, and has grown into a global group with 131 consolidated subsidiaries and 12 affiliated companies. Its business centers on two core segments: Life Care (eyeglass lenses, contact lenses, medical endoscopes, intraocular lenses, etc.) and Information & Communications (mask blanks for semiconductors, photomasks for FPD, glass substrates for HDDs, optical lenses). Of ¥947,749 million in revenue (FY2026, ending March 2026), Life Care accounts for 62% and Information & Communications for 37%, with manufacturing and sales operations deployed globally under a regional headquarters structure covering North America, Europe, and Asia. Major customers span a wide range, including semiconductor and HDD-related companies such as Seagate Technology LLC (accounting for 11.75% of revenue), ophthalmic medical institutions, and eyewear specialty stores.
Business Model
Under the management philosophy of being a "big fish in a small pond," the company prioritizes capturing share in niche markets with limited competition across each business. Manufacturing is conducted at its own factories (in Thailand, Vietnam, China, etc.), and sales are handled through a direct sales system via affiliated companies in each country. Decision-making is accelerated through extensive delegation of authority to business divisions, and while the company withdraws from low-growth businesses (it transferred its Speech Synthesis Software business in October 2025), it acquires new businesses through M&A. The pre-tax profit margin of the Information & Communications segment reached 54.2%, and the group's overall pre-tax profit margin remained at a high level of 34.6% (FY2026, ending March 2026).
Company Strengths
The Information & Communications segment posted a segment profit margin of 54.2% in FY2026 (ending March 2026) (revenue of ¥354,751 million, segment profit of ¥192,325 million). Mask Blanks for Semiconductors has established high technical barriers through the development and mass production of advanced EUV products, achieving an extremely high profit margin against a backdrop of an oligopolistic position that competitors cannot easily enter.
The Life Care segment recorded revenue of ¥590,680 million and a segment profit margin of 21.9% in FY2026 (ending March 2026). It has a multi-layered earnings structure in which multiple product categories steadily build up profit, including high-value-added eyeglass lenses such as Eyeglass Lenses (Progressive Lenses / Meiryo Series) in Europe, private-brand Contact Lenses (hoyaONE), and continued growth of Intraocular Lenses for Cataract Surgery in Japan and Europe.
In FY2026 (ending March 2026), operating cash flow was ¥278,446 million and cash and cash equivalents stood at ¥574,092 million. Against interest-bearing debt of ¥42,241 million, the cash balance was approximately 13.6 times that amount, maintaining a financial structure close to virtually debt-free. The equity attributable to owners of the parent ratio was 78.4% and ROE was 25.4%, achieving both capital efficiency and financial soundness.
ENVALITH's Perspective
Performance Trend
Revenue increased 41.4% over five fiscal periods, from ¥670,325 million in FY2022 (ended March 2022) to ¥947,749 million in FY2026 (ending March 2026). Profit attributable to owners of the parent rose 53.8% over the same period, from ¥164,507 million to ¥253,085 million. In FY2026 (ending March 2026), revenue grew 9.4% and the pre-tax profit margin reached 34.6% (up 4.6pt from 30.0% in the previous fiscal year), reflecting a significant improvement in profitability. External tailwinds included sustained high demand for semiconductors related to EUV, expanding data center investment, and an increase in the yen-converted value of overseas sales due to yen depreciation. On the other hand, it should be noted that the disappearance of one-time gains (gain on the acquisition price allocation difference related to the Chinese joint venture equity interest and gain on business transfer) will affect the profit level in the next fiscal year. Operating cash flow increased 18.4% year on year to ¥278,446 million, confirming a steady improvement in cash generation capability.
Growth Strategy
Continued growth investment in Life Care and Information & Communications, and improved capital efficiency through cash and deposit optimization
Continued R&D and capital investment to meet growing demand for advanced EUV mask blanks amid ongoing semiconductor miniaturization. Capital expenditure in the Information & Communications segment expanded substantially to ¥34,195 million (up 43.2% from ¥23,880 million in the previous fiscal year), with production capacity expansion underway. The trend of increasing DUV demand also continued, and overall electronics-related products achieved revenue of ¥295,757 million.
Life Care segment revenue reached ¥590,680 million (up 7.2% year on year), supported by stable sales of high-value-added eyeglass lenses such as the Eyeglass Lenses (Progressive Lenses / Meiryo Series) in the European market, expansion of the private-brand Contact Lenses (hoyaONE) and new store openings, and continued sales growth of Intraocular Lenses for Cataract Surgery in Japan and Europe. Segment profit increased significantly to ¥129,531 million (up 43.3% year on year).
Given the persistently high ratio of cash and deposits to total assets, the company newly decided to optimize its cash and deposit levels over a period of approximately three years. The policy is to gradually release surplus funds primarily through share buybacks. In FY2026 (ending March 2026), the company conducted share buybacks of ¥171,970 million and paid dividends of ¥99,582 million, and established a progressive dividend policy targeting a payout ratio of around 40%. As a subsequent event, the cancellation of 3,576,300 treasury shares is planned for May 15, 2026.
Photomasks for FPD achieved a substantial increase in revenue driven by the ramp-up of the China plant. Imaging-Related Products (Optical Lenses, Optical Glass Materials, Optics-Related Equipment) achieved ¥58,994 million (up 28.5% from ¥45,927 million in the previous fiscal year), supported by stable demand for interchangeable lenses for mirrorless cameras as well as growth in sales of lenses for wearable cameras and near-infrared polarizing glass (CUPO) for optical communications.
Last updated: July 19, 2026